Woodline Partners’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $12.6M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6.92M | Buy |
|
|||||
|
2023
Q4 | $7.26M | Sell |
|
|||||
|
2023
Q3 | $6.91M | Buy |
|
|||||
|
2023
Q2 | $7.4M | Buy |
|
|||||
|
2023
Q1 | $5.57M | Buy |
|
|||||
|
2022
Q4 | $7.28M | Buy |
|
|||||
|
2022
Q3 | $12.9M | Buy |
|
|||||
|
2022
Q2 | $2.29M | Hold |
|
|||||
|
2022
Q1 | $3.42M | Sell |
|
|||||
|
2021
Q4 | $6.49M | Sell |
|
|||||
|
2021
Q3 | $9.52M | Sell |
|
|||||
|
2021
Q2 | $12.5M | Buy |
|